Discontinuation Criteria for Nucleic Acid Analogues Administered for the Prevention of Hepatitis B Virus Reactivatio
Not Applicable
Recruiting
- Conditions
- Hepatitis B virus reactivation
- Registration Number
- JPRN-UMIN000053257
- Lead Sponsor
- agoya City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who do not meet any of the selection criteria 2)Patients with hematological diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of patients who required reintroduction of NA after discontinuation of NA administered for prevention of HBV reactivation.
- Secondary Outcome Measures
Name Time Method Changes in HBV DNA, HBs antigen, and ALT after discontinuation of NA, and the presence of adverse events such as hepatitis.